ClinicalTrials.gg
RecruitingNCT07854041Updated Oct 2, 2026

Active Release and Myofascial Release Technique in Patients With Patellofemoral Pain Syndrome

An interventional study of Group A and Group B in Patello Femoral Pain Syndrome, sponsored by Riphah International University. Recruiting at 1 site in Pakistan. Open to participants aged 15 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-10-02.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Jun 2026, registered Sep 2026).
  • Started Jun 2026; still recruiting 5 months later.
Updated Oct 2, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
15 Years to 40 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 209 studies in Pain by Riphah International University — 86 open to participants now, 90 under way, none of them phase 3. Pain · Riphah International University.

Planned enrollment
165th of 207
30 · median 38
Started
2026
with 22 others
No phase
207 of 209
86 open now
Primary completion
2026-12
later than 86 of 89 live
Registered
206th of 209
by date

Among the 209 studies in Pain by Riphah International University, this one is the 165th largest by planned enrollment of the 207 interventional ones that give a count, is one of 23 that started in 2026, is one of 207 with no phase, reaches primary completion later than 86 of the 89 other live ones, and was the 206th registered.

Pain

10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.

Browse Pain studies →

Open to participants now

86 of the 209 studies in Pain by Riphah International University are open now, in 1 country. Recruiting first, the newest first:

80 more — sign in →

By country, each count listing its studies:

All 86 open studies →

Where they have run

Who these studies take

Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.

This study: 15 Years to 40 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 209 studies in Pain by Riphah International University, or all of them as a file.
02

Study summary

Patellofemoral pain syndrome (PFPS) is often associated with imbalance and weakness in several key muscle group. These include the quadriceps (especially the vastus medialis oblique), hip abductors and external rotators and hamstrings as well as tightness in iliotibial band and gastrocnemius. Exercises involving isometrics, stretching, strengthening of knee along with core muscles has improved range, strength, coordination and motor control. This study aim to determine the effects of active release along with myofascial release technique on pain, range of motion and function in patients with patellofemoral pain syndrome.

This study will be a randomized controlled trial and will be conducted in Riphah Rehabilitation Clinic Lahore (Physiotherapy Department) and Ghurki Trust Hospital Lahore. Non-probability consecutive sampling will be used to collect the data. Sample size of 30 subjects with age group between 15-40 years will be taken. Data will be collected from the patients having present complaint of anterior knee pain. Outcome measures will be taken by using Numeric pain rating scale (NPRS), Anterior knee pain scale (AKPS)for pain, Universal Goniometer (GU) for Range of motion and KOOS PS scale to assess physical function in patient with knee pain. An informed consent will be taken. Subjects will be selected on the basis of inclusion and exclusion criteria and will be equally divided into two groups by random number generator table. Both the Groups will receive RICE protocol, ice, stretching, strengthening and knee isometrics exercises, while Group A will receive active release and Group B will receive myofascial release technique. Outcome measures will be measured at baseline and after 6 weeks. Data analysis will be done by SPSS version 25.

Read the detailed description

Patellofemoral pain syndrome (PFPS) is a prevalent source of knee pain among adolescents and young adults. It is defined as pain occurring in the prepatellar or retropatellar region that worsens during prolonged sitting, kneeling, squatting, and stair climbing. Patellofemoral pain syndrome (PFPS) is a musculoskeletal disorder characterized by anterior knee pain, typically resulting from increased stress on the patellofemoral joint. Patellofemoral pain syndrome (PFPS) is a broad term that covers various conditions affecting the patellofemoral joint (PFJ), including extensor mechanism dysfunction, patellar subluxation, and runner's knee. PFPS is usually characterized by physical and biomechanical changes within the joint, which may involve altered patellar tracking, muscle imbalances, and soft tissue restrictions, such as weakness in the quadriceps or tightness in the hamstring muscles, all contributing to joint dysfunction and pain.

The prevalence of PFPS in adolescents is between 20 and 40%, with around 1 in 10 male recruits experiencing the condition. A study on a mixed-gender recruitment population found that the prevalence of the condition in females was about 2.23 times higher than in males. The annual prevalence rate for the general adult population was reported to be 22.7%, with rates of 29.2% for women and 15.5% for men. The aetiology of PFPS is unknown, although muscle imbalance, tendonitis, or insertional tendinosis of the extensor apparatus, patellar instability, and chondral and osteochondral damage can be involved in the pathogenesis of the disease. A combination of factors, such as abnormal lower limb biomechanics, soft-tissue tightness, muscle weakness, and excessive exercise may result in increased cartilage and subchondral bone stress and subsequent PFPS.

There is clear consensus that the etiology of patellofemoral pain syndrome (PFPS) is multifactorial in nature. Several risk factors have been proposed as possible parameters involved in pathogenesis of PFPS. These risk factors are classified as intrinsic or extrinsic risk factors. Extrinsic risk factors are related to factors outside human body, such as the type of sports activity, environmental conditions, and the surface and equipment used. Intrinsic risk factors relate more to individual characteristics. The review of existing literature has shown that some modifiable risk factors have been theorized to play a role in the development and persistence of PFPS, including quadriceps weakness, specifically in vastus medialis oblique (VMO) , tightness of hamstring , tightness of iliopsoas , tightness of iliotibial band , tightness of gastrosoleous , hip muscles dysfunction, especially abductors and external rotators , foot over pronation , generalized joint laxity , limb length discrepancy , patellar malalignment and patellar hypermobility.

Active Release Techniques (ART) is a noninvasive, soft tissue treatment process that both locates and breaks down the scar tissue and adhesions which cause pain, stiffness, weakness, numbness, and physical dysfunctions associated with Repetitive Strain Injuries. ART is used both for the treatment of RSI injuries, as well as for the improvement of athletic performance. ART aims to return complete translation or relative motion to the full length of the affected soft tissue and to its adjacent soft-tissue structures. Active release techniques (ART) is classified as a multidisciplinary procedure that is practiced by numerous practitioners from a wide range of medical professions and disciplines, including Chiropractors, Physiotherapists, Massage Therapists, Kinesiologists, Occupational Therapists, and Sports physicians. The goals of ART are to restore optimal tissue texture, tension and movement, restore the strength, flexibility, function, and relative translation between soft tissue layers, release any soft tissue restrictions, entrapped nerve, restricted circulatory structures, or lymphatic restrictions. ART is used to normal texture, tension, and length by using various hand positions and soft tissue manipulation methods.

MFR techniques focus on relieving tension and restoring flexibility in the fascia and muscles surrounding the knee joint. This technique can be performed through palpation of tight muscle areas, use of compressive techniques to mobilize muscle tissue, and use of dynamic movements to release fascial restrictions. The release is maintained until relaxation is perceived, ensuring the tissue is restored to its natural state.

03

Conditions studied

  • Patello Femoral Pain Syndrome

Browse trials for

Keywords

  • Active release technique
  • Anterior knee pain
  • Range of motion
  • myofascial release
  • Patello Femoral pain Syndrome
04

Who can participate

Ages eligible
15 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Experience retro patellar pain for at least three months, including pain at rest or during activities such as ascending or descending stairs, jumping, running, squatting, kneeling, or prolonged sitting (12).
  • Patients with + ive Squat test in the absence of any pathology
  • Patients also must have presented with an insidious onset of symptoms unrelated to trauma and a positive Clark test (19).
  • Reduced knee range of motion, especially extension

Exclusion criteria

Exclusion Criteria:

  • A history of significant lower extremity, pelvic, or spinal surgery/fracture, or traumatic lesions of ligaments or meniscus within the past six months.
  • Presence of other orthopedic conditions (e.g., ACL rupture, meniscal tears), neurological disorders (e.g., multiple sclerosis, paralysis), rheumatological diseases (e.g., rheumatoid arthritis, ankylosing spondylitis), or congenital conditions leading to osteoarthrosis.
  • Current pregnancy
  • A history of connective tissue disease, patellofemoral dislocation or subluxation, osteoarthrosis of the knees.

Other forms of anterior knee pain (e.g., Osgood-Schlatter disease, tendon pain, bursitis). A history of referred pain from the lumbar spine (12). or

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Active release technique

    Before applying active release technique, assess the knee joint, by palpating the area of tightness, tenderness and restricted movement .Then apply specific pressure to affected tissues, such as the quadriceps, hamstrings, iliotibial band (IT band) or patellar tendon, depending on the findings of the evaluation. The patient will then actively move the knee joint through prescribed range of motions, while the therapist maintain contact and provides appropriate pressure. This process is repeated several times, with the therapist adjusting pressure and movements as needed to improve tissue mobility and reduce pain.

    Other: Group A

  • Active comparator
    Myofascial Release Technique

    For Myofascial release technique therapist will use their hands to apply sustained pressure to restricted areas fascia, gradually lengthening and releasing the tissue. Gentle stretching techniques can also be used to lengthen the tissue and muscles, improving flexibility and range of motion.

    Other: Group B

Interventions

  • OtherGroup A

    Before applying active release technique, assess the knee joint, by palpating the area of tightness, tenderness and restricted movement .Then apply specific pressure to affected tissues, such as the quadriceps, hamstrings, iliotibial band (IT band) or patellar tendon, depending on the findings of the evaluation. The patient will then actively move the knee joint through prescribed range of motions, while the therapist maintain contact and provides appropriate pressure. This process is repeated several times, with the therapist adjusting pressure and movements as needed to improve tissue mobility and reduce pain.

  • OtherGroup B

    For Myofascial release technique therapist will use their hands to apply sustained pressure to restricted areas fascia, gradually lengthening and releasing the tissue. Gentle stretching techniques can also be used to lengthen the tissue and muscles, improving flexibility and range of motion.

06

What researchers measure

Primary outcomes

  1. Lower Extremity Functional Scale

    The lower extremity functional scale (LEFS) is a valid patient-rated outcome measure (PROM) for the measurement of lower extremity function. The scale consist of 4 groups with 20 questions. The questions in these group focus on activities with increasing physical demands like questions from walking between rooms to running on uneven ground. The scoring of this scale varies from 0 (extreme difficulty/unable to perform activity) to 4 (no difficulty). The total score can be obtained by summing the scores of the individual items. The maximum score of 80 indicates no functional limitations and the minimum score of 0 indicates extreme limitations

    Time frame: Baseline; 6 Weeks

  2. Patellofemoral Pain and Osteoarthritis Subscale of Knee injury and Osteoarthritis Outcome Score

    Patellofemoral pain and patellofemoral osteoarthritis are highly prevalent knee disorders associated with pain and functional limitations. The subscale of the Knee Injury and Osteoarthritis Outcome Score for patellofemoral pain and osteoarthritis (KOOS-PF) was developed to evaluate patients with patellofemoral pain and osteoarthritis.

    Time frame: Basleine; 6 Weeks

  3. Visual Analogue Scale

    The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" and "worst pain"

    Time frame: Baseline; 6 Week

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Khammar F, Taghizadeh Delkhoush C, Ehsani F. Study of the electromyographic activity in patellofemoral pain syndrome accompanied by secondary myofascial pain syndrome specifically affecting the popliteus muscle following dry needling: a randomized clinical trial. J Man Manip Ther. 2025 Jun;33(3):195-206. doi: 10.1080/10669817.2024.2396709. Epub 2024 Aug 28. PubMed 39196042 ↗
  • Kaya D, Callaghan MJ, Ozkan H, Ozdag F, Atay OA, Yuksel I, Doral MN. The effect of an exercise program in conjunction with short-period patellar taping on pain, electromyogram activity, and muscle strength in patellofemoral pain syndrome. Sports Health. 2010 Sep;2(5):410-6. doi: 10.1177/1941738110379214. PubMed 23015969 ↗
  • Mv VK, Subramanian NB, S S, Kotamraju S, Krishnan M. Physiotherapeutic interventions on quadriceps muscle architecture in patello-femoral pain syndrome. Bioinformation. 2023 Apr 30;19(4):454-459. doi: 10.6026/97320630019454. eCollection 2023. PubMed 37822824 ↗
  • Callaghan MJ, Selfe J. Patellar taping for patellofemoral pain syndrome in adults. Cochrane Database Syst Rev. 2012 Apr 18;2012(4):CD006717. doi: 10.1002/14651858.CD006717.pub2. PubMed 22513943 ↗
  • Petersen W, Rembitzki IV, Bruggemann GP, Ellermann A, Best R, Koppenburg AG, Liebau C. Anterior knee pain after total knee arthroplasty: a narrative review. Int Orthop. 2014 Feb;38(2):319-28. doi: 10.1007/s00264-013-2081-4. Epub 2013 Sep 22. PubMed 24057656 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2026 (actual). Primary completion is estimated for Dec 2026, 6 months after the start.

Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 6 months is below that.

Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 27, 2026
First posted
Oct 2, 2026
StartActual
Jun 1, 2026
Primary completionEst.
Dec 1, 2026
CompletionEst.
Jan 1, 2027
Last update
Oct 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 2, 2026
Show all 1 update
  1. Oct 2, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07854041
Responsible party
Sponsor
First posted
Oct 2, 2026
Start date
Jun 1, 2026
Primary completion
Dec 1, 2026 (estimated)
Completion
Jan 1, 2027 (estimated)
Last update
Oct 2, 2026

Study contacts

Syed Shakil ur Rehman, PhD
Contact
shakil.urrehman@riphah.edu.pk
+92 320 786661
Syed Shakil ur Rehman, PhD
principal investigator · Riphah International University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion